Drugs for Rheumatoid Arthritis: Global Markets to 2022

Table of Contents

1 Introduction

• Study Goals and Objectives
  
• Reasons for Doing This Study
  
• Scope of Report
  
• Information Sources
  
• Methodology
  
• Currencies
  
• Geographic Breakdown
  
• Analyst's Credentials
  

2 Summary and Highlights

3 Drugs for Rheumatoid Arthritis Market Characteristics

4 Drugs for Rheumatoid Arthritis Market Size and Growth

• Historic Market Growth
  
• Drivers of the Market
  
• Restraints on the Market
  
• Forecast Market Growth
  
• Drivers of the Market
  
• Restraints on the Market
  

5 Drugs for Rheumatoid Arthritis Market Trends and Strategies

• Increasing Use of Technology
  
• 3D Printing Technologies
  
• Combo and Mono Therapy
  
• New Applications of NSAIDS
  

6 PESTLE Analysis

• Political
  
• Government Financial Support
  
• Uncertain Political Policies
  
• Economic
  
• Wealth
  
• Globalization
  
• Emerging Markets
  
• Social
  
• Ageing Global Population
  
• Sedentary Lifestyles
  
• Health Consciousness and Awareness
  
• Traditional Medicine Continues to Pose Threat to Market
  
• Technological
  
• 3D Printing Technologies
  
• Internet Penetration and Mobile Applications
  
• Legal
  
• Stringent Regulations and Long Approval Procedures
  
• Investment Regulations
  
• Patent Issues
  
• Government Intervention
  
• Environmental
  

7 Drugs for Rheumatoid Arthritis Market Segmentation

• Global Drugs for Rheumatoid Arthritis Market, By Segment
  
• Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  
• Disease Modifying Anti-Rheumatic Drugs (DMARDs)
  
• Market Characteristics
  
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  
• Market Characteristics
  
• Corticosteroids
  
• Market Characteristics
  

8 Drugs for Rheumatoid Arthritis Market Regional and Country Analysis

• Global Drugs for Rheumatoid Arthritis Market, By Region
  
• Global Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Region
  
• Global Drugs for Rheumatoid Arthritis Market Segmentation, By Region, 2017
  
• Global Drugs for Rheumatoid Arthritis Market, By Country
  
• Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Country
  
• Global Drugs for Rheumatoid Arthritis Market Segmentation, 2017, By Country
  

9 Global Drugs for Rheumatoid Arthritis Market Comparison with Macro Economic Factors

• Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure
  
• Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, By Country
  

10 Asia-Pacific Drugs for Rheumatoid Arthritis Market

• Asia-Pacific Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Government Initiatives
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Major Associations
  
• Import and Export Duties
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Competitive Landscape
  
• Asia-Pacific Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• Asia-Pacific Drugs for Rheumatoid Arthritis Market Forecast Market
  
• Asia-Pacific Drugs for Rheumatoid Arthritis Market, By Segment
  
• Asia-Pacific Drugs for Rheumatoid Arthritis Market, Historic and Forecast CAGR, By Segment
  

11 Asia-Pacific Drugs for Rheumatoid Arthritis Market: Country Analysis

• China Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Major Associations
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Competitive Landscape
  
• China Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• China Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  
• China Market Size, By Segment
  
• China Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  
• India Drugs for Rheumatoid Arthritis Market Overview
  
• Country Information
  
• Background Information
  
• End User Customer Information
  
• Government Initiatives
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Major Associations
  
• Import and Export Duties
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Competitive Landscape
  
• India Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• India Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  
• India Market Size, By Segment
  
• India Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  
• Japan Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Major Associations
  
• Major Companies
  
• Japan Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• Japan Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  
• Japan Market Size, By Segment
  
• Japan Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  
• Australia Drugs for Rheumatoid Arthritis Market
  
• Australia Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• Australia Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  
• Australia Market Size, By Segment
  
• Australia Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  

12 Western Europe Drugs for Rheumatoid Arthritis Market

• Western European Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Government Initiatives
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Import and Export Duties
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Competitive Landscape
  
• Western Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• Western Europe Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• Western Europe Market Size, By Segment
  
• Western Europe Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  

13 Western Europe Drugs for Rheumatoid Arthritis Market: Country Analysis

• UK Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Government Initiatives
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Major Associations
  
• Import and Export Duties
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Competitive Landscape
  
• UK Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• UK Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• UK Market Size, By Segment
  
• UK Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  
• Germany Drugs for Rheumatoid Arthritis Market
  
• Germany Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• Germany Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• Germany Market Size, By Segment
  
• Germany Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  
• France Drugs for Rheumatoid Arthritis Market
  
• France Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• France Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• France Market Size, By Segment
  
• France Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  
• Italy Drugs for Rheumatoid Arthritis Market
  
• Italy Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• Italy Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  
• Italy Market Size, By Segment
  
• Italy Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  
• Spain Drugs for Rheumatoid Arthritis Market
  
• Spain Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• Spain Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• Spain Market Size, By Segment
  
• Spain Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  

14 Eastern Europe Drugs for Rheumatoid Arthritis Market

• Eastern European Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Major Associations
  
• Import and Export Duties
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Competitive Landscape
  
• Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• Eastern Europe Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• Eastern Europe Market Size, By Segment
  
• Eastern Europe Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  

15 Eastern Europe Drugs for Rheumatoid Arthritis Market: Country Analysis

• Russia Drugs for Rheumatoid Arthritis Market
  
• Russia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• Russia Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• Russia Market Size, By Segment
  
• Russia Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  

16 North America Drugs for Rheumatoid Arthritis Market

• North America Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Government Initiatives
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Major Associations
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Competitive Landscape
  
• North America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• North America Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• North America Market Size, By Segment
  
• North America Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
  

17 North America Drugs for Rheumatoid Arthritis Market: Country Analysis

• USA Drugs for Rheumatoid Arthritis Market
  
• USA Drugs for Rheumatoid Arthritis Market Historic Market, 2013-2017
  
• USA Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  
• USA Market Size, By Segment
  
• USA Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Segment
  

18 South America Drugs for Rheumatoid Arthritis Market

• South America Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Government Initiatives
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Major Associations
  
• Import and Export Duties
  
• Taxes Levied
  
• Corporate Tax Structure
  
• Competitive Landscape
  
• South America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• South America Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• South America Market Size, By Segment
  
• South America Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
  

19 South America Drugs for Rheumatoid Arthritis Market: Country Analysis

• Brazil Drugs for Rheumatoid Arthritis M
  
• Brazil Drugs for Rheumatoid Arthritis Historic Market, 2013-2016
  
• Brazil Drugs for Rheumatoid Arthritis Market Forecast Market, 2017-2022
  
• Brazil Market Size, By Segment
  
• Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
  

20 Middle East Drugs for Rheumatoid Arthritis Market

• Middle Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Government Initiatives
  
• Major Contracts/ Research and Development Projects
  
• Regulatory Bodies
  
• Regulations
  
• Major Associations
  
• Import and Export Duties
  
• Taxes Levied
  
• Competitive Landscape
  
• Middle East Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• Middle East Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• Middle East Market Size, By Segment
  
• Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
  

21 Africa Drugs for Rheumatoid Arthritis Market

• Africa Drugs for Rheumatoid Arthritis Market Overview
  
• Region Information
  
• Background Information
  
• End User Customer Information
  
• Government Initiatives
  
• Regulations
  
• Regulatory Bodies
  
• Major Associations
  
• Competitive Landscape
  
• Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
  
• Africa Drugs for Rheumatoid Arthritis Forecast Market, 2017-2022
  
• Africa Market Size, By Segment
  
• Africa Drugs for Rheumatoid Arthritis Historic and Forecast Market, By Segment, 2013-2022
  

22 Drugs for Rheumatoid Arthritis Market Customer Information

• Frequency of Pain after Treatment
  
• Different Symptoms Experienced by Patients
  
• Impact of Rheumatoid Arthritis at Workplace
  
• Importance of Patient’s Role in the Management of Rheumatoid Arthritis
  
• Capacity of Affordable Treatment
  

23 Drugs for Rheumatoid Arthritis Market Competitive Landscape

• Company Profiles
  
• Abbvie Inc.
  
• Amgen Inc.
  
• Bristol-Myers Squibb Company
  
• F. Hoffmann-La Roche AG
  
• Pfizer
  

24 Key Mergers and Acquisitions in the Drugs for Rheumatoid Arthritis Market

• Pfizer Acquired Hospira
  
• Concordia Healthcare Acquired Covis Pharma Commercial Assets
  
• Bristol-Myers Squibb Acquired Padlock Therapeutics
  
• Alvotech Acquired Baliopharm
  
• Atnahs Acquired Pharmaceutical Assets of F. Hoffmann-La Roche
  

25 Appendix

• Definitions of the Industry
  
• Drugs for Rheumatoid Arthritis
  
• Research Methodology
  

26 References

List of Tables
Summary Table : Global Drugs for Rheumatoid Arthritis Market, Through 2022
Table 1 : Global Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 2 : Global Drugs for Rheumatoid Arthritis Market, Through 2022
Table 3 : Global Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 4 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 5 : Global Drugs for Rheumatoid Arthritis Market, by Region, 2017
Table 6 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Region, Through 2022
Table 7 : Global Drugs for Rheumatoid Arthritis Market Segmentation, by Region, 2017
Table 8 : Global Drugs for Rheumatoid Arthritis Market, by Country, 2017
Table 9 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Country, 2013-2022
Table 10 : Global Drugs for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Table 11 : Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, 2013-2022
Table 12 : per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, by Country, 2017
Table 13 : Asia-Pacific-Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 14 : Asia-Pacific Drugs for Rheumatoid Arthritis Market, Through 2022
Table 15 : Asia-Pacific Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 16 : Asia-Pacific Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Table 17 : China Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 18 : China Drugs for Rheumatoid Arthritis Market, Through 2022
Table 19 : China Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 20 : China Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 21 : India Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 22 : India Drugs for Rheumatoid Arthritis Market, Through 2022
Table 23 : India Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 24 : India Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 25 : Japan Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 26 : Japan Drugs for Rheumatoid Arthritis Market, Through 2022
Table 27 : Japan Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 28 : Japan Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 29 : Australia Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 30 : Australia Drugs for Rheumatoid Arthritis Market, Through 2022
Table 31 : Australia Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 32 : Australia Drugs for Rheumatoid Arthritis Market Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 33 : Western Europe Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 34 : Western Europe Drugs for Rheumatoid Arthritis Market, Through 2022
Table 35 : Western Europe Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 36 : Western Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 37 : UK Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 38 : UK Drugs for Rheumatoid Arthritis Market, Through 2022
Table 39 : UK Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 40 : UK Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 41 : Germany Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 42 : Germany Drugs for Rheumatoid Arthritis Market, Through 2022
Table 43 : Germany Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 44 : Germany Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 45 : France Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 46 : France Drugs for Rheumatoid Arthritis Market, Through 2022
Table 47 : France Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 48 : France Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 49 : Italy Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 50 : Italy Drugs for Rheumatoid Arthritis Market, Through 2022
Table 51 : Italy Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 52 : Italy Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 53 : Spain Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 54 : Spain Drugs for Rheumatoid Arthritis Market, 2017-2022
Table 55 : Spain Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 56 : Spain Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 57 : Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 58 : Eastern Europe Drugs for Rheumatoid Arthritis Market, Through 2022
Table 59 : Eastern Europe Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 60 : Eastern Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 61 : Russia Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 62 : Russia Drugs for Rheumatoid Arthritis Market, Through 2022
Table 63 : Russia Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 64 : Russia Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 65 : North America Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 66 : North America Drugs for Rheumatoid Arthritis Market, Through 2022
Table 67 : North America Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 68 : North America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 69 : USA Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 70 : USA Drugs for Rheumatoid Arthritis Market, Through 2022
Table 71 : USA Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 72 : USA Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, Through 2022
Table 73 : South America Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 74 : South America Drugs for Rheumatoid Arthritis Market, Through 2022
Table 75 : South America Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 76 : South America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, Through 2022
Table 77 : Brazil Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 78 : Brazil Drugs for Rheumatoid Arthritis Market, Through 2022
Table 79 : Brazil Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 80 : Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 81 : Middle East Drugs for Rheumatoid Arthritis Historic Market, Through 2017
Table 82 : Middle East Drugs for Rheumatoid Arthritis Market, Through 2022
Table 83 : Middle East Drugs for Rheumatoid Arthritis Market, By Segments, 2017
Table 84 : Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 85 : Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Table 86 : Africa Drugs for Rheumatoid Arthritis Market, Through 2022
Table 87 : Africa Drugs for Rheumatoid Arthritis Market, By Segment, 2017
Table 88 : Africa Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Table 89 : Global Market Shares for Key Competitors of Drugs for Rheumatoid Arthritis, 2017
Table 90 : AbbVie Inc. Financial Performance, 2013 - 2017
Table 91 : Amgen Inc. Financial Performance, 2013 - 2017
Table 92 : Bristol-Myers Squibb Financial Performance, 2013 - 2017
Table 93 : F. Hoffmann-La Roche Financial Performance, 2013 - 2017
Table 94 : Pfizer Inc. Financial Performance, 2013 - 2017
Table 95 : Market Data Sources

List of Figures
Summary Figure : Global Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 1 : Global Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 2 : Global Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 3 : PESTLE Analysis: Global drugs for rheumatoid arthritis market, 2017
Figure 4 : Global Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 5 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 6 : Global Drugs for Rheumatoid Arthritis Market Share, by Region, 2017
Figure 7 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Region, 2013-2022
Figure 8 : Global Drugs for Rheumatoid Arthritis Market Segmentation, by Region, 2017
Figure 9 : Global Drugs for Rheumatoid Arthritis Market Share, by Country, 2017
Figure 10 : Global Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Country, 2013-2022
Figure 11 : Global Drugs for Rheumatoid Arthritis Market Segmentation, by Country, 2017
Figure 12 : Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, 2013-2022
Figure 13 : Asia-Pacific Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 14 : Asia-Pacific Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 15 : Asia-Pacific Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 16 : Asia-Pacific Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 17 : China Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 18 : China Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 19 : China Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 20 : China Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 21 : India Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 22 : India Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 23 : India Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 24 : India Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 25 : Japan Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 26 : Japan Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 27 : Japan Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 28 : Japan Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market by Segment, 2013-2022
Figure 29 : Australia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 30 : Australia Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 31 : Australia Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 32 : Australia Drugs for Rheumatoid Arthritis Market Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 33 : Western Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 34 : Western Europe Drugs for Rheumatoid Arthritis market, 2017-2022
Figure 35 : Western Europe Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 36 : Western Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 37 : UK Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 38 : UK Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 39 : UK Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 40 : UK Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 41 : Germany Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 42 : Germany Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 43 : Germany Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 44 : Germany Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 45 : France Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 46 : France Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 47 : France Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 48 : France Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 49 : Italy Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 50 : Italy Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 51 : Italy Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 52 : Italy Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 53 : Spain Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 54 : Spain Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 55 : Spain Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 56 : Spain Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 57 : Eastern Europe Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 58 : Eastern Europe Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 59 : Eastern Europe Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 60 : Eastern Europe Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 61 : Russia Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 62 : Russia Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 63 : Russia Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 64 : Russia Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 65 : North America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 66 : North America Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 67 : North America Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 68 : North America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 69 : USA Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 70 : USA Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 71 : USA Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 72 : USA Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 73 : South America Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 74 : South America Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 75 : South America Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 76 : South America Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segment, 2013-2022
Figure 77 : Brazil Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 78 : Brazil Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 79 : Brazil Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 80 : Brazil Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 81 : Middle East Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 82 : Middle East Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 83 : Middle East Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 84 : Middle East Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 85 : Africa Drugs for Rheumatoid Arthritis Historic Market, 2013-2017
Figure 86 : Africa Drugs for Rheumatoid Arthritis Market, 2017-2022
Figure 87 : Africa Drugs for Rheumatoid Arthritis Market Share, by Segment, 2017
Figure 88 : Africa Drugs for Rheumatoid Arthritis Historic and Forecast Growth Rate Market, by Segments, 2013-2022
Figure 89 : Global Market Shares for Key Competitors of Drugs for Rheumatoid Arthritis, 2017
Figure 90 : AbbVie Inc. Financial Performance, 2013-2017
Figure 91 : Amgen Inc. Financial Performance, 2013-2017
Figure 92 : Bristol-Myers Squibb Financial Performance, 2013-2017
Figure 93 : F. Hoffmann-La Roche Financial Performance, 2013-2017
Figure 94 : Pfizer Inc. Financial Performance, 2013-2017

Samples

Companies Mentioned

• AbbVie Inc.
  
• Amgen Inc.
  
• Biogen 0.6 10.8 Merck & Co.
  
• Bristol-Myers Squibb
  
• Hoffmann-La Roche
  
• Johnson & Johnson
  
• Mitsubishi Tanabe Pharma Corporation
  
• Pfizer
  
• UCB S.A.